Allelic Losses at 1p, 9q, 10q, 14q, and 22q in the Progression of Aggressive Meningiomas and Undifferentiated Meningeal Sarcomas

Lantos, 1997, Tumours of the nervous system, 583

Louis, 1997, Meningiomas, 134

Kleihues, 1993

Simon, 1995, Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas, Cancer Res, 55, 4696

Weber, 1997, Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas, PNAS USA, 94, 14719, 10.1073/pnas.94.26.14719

Dumanski, 1987, Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma, Proc Natl Acad Sci USA, 84, 59275, 10.1073/pnas.84.24.9275

Zankl, 1972, Cytological and cytogenetical studies on brain tumors. IV. Identification of the missing G chromosome in human meningiomas as No. 22 by fluorescence technique, Humangenetik, 14, 167, 10.1007/BF00273305

Westphal, 1989, Spectrum of karyotypic aberrations in cultured human meningiomas, Cytogenet and Cell Genet, 52, 45, 10.1159/000132837

Ruttledge, 1994, Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas, Nat Genet, 6, 180, 10.1038/ng0294-180

Lekanne Deprez, 1994, Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas, Am J Hum Genet, 54, 1022

Wellenreuther, 1995, Analysis of the neurofibromatosis gene reveals molecular variants of meningioma, Am J Pathol, 146, 827

Bello, 1994, Allelic loss at 1p is associated with tumor progression of meningiomas, Genes Chromosom Cancer, 9, 296, 10.1002/gcc.2870090411

Lekanne Deprez, 1995, Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas, J Neuropathol Exp Neurol, 54, 224, 10.1097/00005072-199503000-00009

Niedermayer, 1997, Loss of alkaline phosphatase activity in meningiomas, J Neuropathol Exp Neurol, 56, 879, 10.1097/00005072-199708000-00006

Rempel, 1993, Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression, Cancer Res, 53, 2386

Li, 1997, PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer, Science, 275, 1943, 10.1126/science.275.5308.1943

Steck, 1997, Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers, Nature Genet, 15, 356, 10.1038/ng0497-356

Boström, 1998, Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q, Cancer Res, 58, 29

Menon, 1997, Frequent loss of chromosome 14 in atypical and malignant meningioma, Oncogene, 14, 611, 10.1038/sj.onc.1200853

Tse, 1997, Loss of heterozygosity of chromosome 14q in low- and high-grade meningiomas, Human Pathol, 28, 779, 10.1016/S0046-8177(97)90149-0

Nowell, 1986, Mechanisms of tumor progression, Cancer Res, 46, 2203

Zhu, 1995, Analysis of meningiomas by methylation- and transcription-based clonality assays, Cancer Res, 55, 3865

Wu, 1996, Clonal analysis of meningiomas, Neurosurgery, 38, 1196

Joseph, 1995, NF2 gene analysis distinguishes hemangiopericytoma from meningioma, Am J Pathol, 147, 1450

Jääskeläinen, 1997, Haemangiopericytoma, 146